RODNEY COLLINS: Open Payments
NPI 1700879061 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,620 in 247 payments from 23 companies in 2025. Trend: 2023 $5,194 · 2024 $8,166 · 2025 $7,620
Food & beverage: $7,612Education: $8
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $1,005 |
| Janssen Pharmaceuticals, Inc | 15 | $988 |
| Vanda Pharmaceuticals Inc. | 30 | $817 |
| Alkermes, Inc. | 15 | $647 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $533 |
| E.R. Squibb & Sons, L.L.C. | 20 | $533 |
| Axsome Therapeutics, Inc. | 21 | $499 |
| Otsuka America Pharmaceutical, Inc. | 16 | $449 |
| Lundbeck LLC | 18 | $388 |
| ViiV Healthcare Company | 7 | $311 |
Products named: VRAYLAR, FANAPT, INVEGA SUSTENNA, REXULTI, CAPLYTA, Auvelity, ARISTADA, COBENFY.
Industry payments across CA — which companies pay providers there.
